Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed)

The summary for the Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed): This Funding Opportunity Announcement (FOA) invites applications to serve as the Data Coordinating Center (DCC) that will support the activities of the Lung Transplant Consortium (LTC). The primary responsibility of the DCC will be to oversee the conduct of multiple observational clinical studies involving lung transplantation in the LTC. The DCC will support regulatory and administrative activities, data and biospecimen collection and management, statistical analyses, and the reporting of study results in a timely manner. The DCC will promote collaboration and communication among LTC investigators and the broader research community and will coordinate outreach activities including engaging foundations, societies, and other entities with a shared interest in lung transplantation. The DCC will be responsible for integrating the efforts of approximately 24 individual LTC Clinical Centers performing observational research studies to identify factors that impact donor lung utilization and the development of acute lung allograft dysfunction in lung transplant recipients. The NHLBI anticipates that the DCC will collaborate strategically with the LTC Clinical Centers to provide support for protocol development, statistical data analyses, biospecimen collection and storage, the publication of results, and providing datasets for secondary analyses by the broader research community. This FOA runs in parallel with a separate FOA that invites applications for the LTC Clinical Centers, described in detail in RFA-HL-22-002
Federal Grant Title: Lung Transplant Consortium - Data Coordinating Center (U24 - Clinical Trial Not Allowed)
Federal Agency Name: National Institutes of Health (HHS-NIH11)
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HL-22-003
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.838
CFDA Descriptions: Information not provided
Current Application Deadline: June 15th, 2021
Original Application Deadline: June 15th, 2021
Posted Date: February 25th, 2021
Creation Date: February 25th, 2021
Archive Date: July 21st, 2021
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Last Updated: February 25th, 2021
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement
Grant Announcement Contact
NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Similar Government Grants
Limited Competition: Physician Scientist Transition to Independence in Blood Science Resea...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordi...
Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissu...
Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clin...
Pathogenesis of Sars Lung Disease: in Vitro Studies and Animal Models
Lung Response to Inhaled Highly Toxic Chemicals
Protein Interactions Governing Membrane Transport in Pulmonary Health and Disease (R01)
More Grants from the National Institutes of Health
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required...
NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 -...
HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)
Single Source: NINDS Exploratory Clinical Trials (U01 Clinical Trial Required)
Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024